New Imaging Agent Myeliviz May Provide Earlier Diagnosis For MS Patients
Feb 03, 2020, 12:00 AM
Share
Subscribe
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the new imaging agent Myeliviz, currently in clinical trial for use in MS diagnosis.
Are you interested in learning more about Multiple Sclerosis? If so, please visit https://multiplesclerosisnewstoday.com/
